Emiel Ruijter
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Sarcoma Diagnosis and Treatment
- Rheumatology top 10%
- Soft tissue tumor case studies
- Urologic and reproductive health conditions
Papers in
-
- Prostate Cancer Diagnosis and Treatment 6
- Prostate Cancer Treatment and Research 4
- Sarcoma Diagnosis and Treatment 1
-
- Cancer-related gene regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- Epigenetics and DNA Methylation 1
- Co-authors
- F.M.J. Debruyne (9 shared papers)Jack A. Schalken (7 shared papers)Dirk J. Ruiter (3 shared papers)C A van de Kaa (4 shared papers)Gary J. Miller (5 shared papers)Jean de la Rosette (3 shared papers)Geert J.L.H. van Leenders (2 shared papers)Harrie P. Beerlage (2 shared papers)
- Journals
- The Journal of Pathology (4 papers)Diagnostic Pathology (2 papers)European Urology (2 papers)Histopathology (1 paper)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (1 paper)
- Partner nations
- NetherlandsUnited StatesJapan
In The Last Decade
Emiel Ruijter
16 papers receiving 851 citations
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 504
- Rheumatology 130
- Oral Surgery 40
- Cancer Research 82
- Urology 21
Countries citing papers authored by Emiel Ruijter
This map shows the geographic impact of Emiel Ruijter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiel Ruijter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiel Ruijter more than expected).
Fields of papers citing papers by Emiel Ruijter
This network shows the impact of papers produced by Emiel Ruijter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiel Ruijter. The network helps show where Emiel Ruijter may publish in the future.
Co-authors
The 25 scholars most cited alongside Emiel Ruijter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 152 | |
| 2 | 1996 | 151 | |
| 3 | 1999 | 89 | |
| 4 | 2000 | 87 | |
| 5 | 2014 | 85 | |
| 6 | 1997 | 64 | |
| 7 | 1999 | 54 | |
| 8 | 2000 | 46 | |
| 9 | 1997 | 45 | |
| 10 | 1998 | 40 | |
| 11 | 2000 | 28 | |
| 12 | 2001 | 11 | |
| 13 | 2019 | 11 | |
| 14 | 1998 | 7 | |
| 15 | 2002 | 3 | |
| 16 | 2013 | 1 | |
| 17 | 2025 | 0 |
About Emiel Ruijter
Emiel Ruijter is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Rheumatology, Pathology and Forensic Medicine and Oncology, having authored 17 papers that have together received 874 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (4 papers), Urologic and reproductive health conditions (3 papers), Cancer-related gene regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Genetic factors in colorectal cancer (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (504 citations), Rheumatology (130 citations), Oral Surgery (40 citations), Cancer Research (82 citations) and Urology (21 citations). Emiel Ruijter has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include F.M.J. Debruyne, Jack A. Schalken, Dirk J. Ruiter, C A van de Kaa, Gary J. Miller, Jean de la Rosette, Geert J.L.H. van Leenders, Harrie P. Beerlage, Gosse O.N. Oosterhof and J.A. Witjes. Their work appears in journals such as The Journal of Pathology, Diagnostic Pathology, European Urology, Histopathology and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.